FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

870525003: Ozanimod (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2020. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3969941012 Ozanimod en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3969942017 Ozanimod (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Ozanimod Is a Immunosuppressant (substance) true Inferred relationship Some
Ozanimod Is a Indene true Inferred relationship Some
Ozanimod Is a Substance with sphingosine 1-phosphate receptor agonist mechanism of action (substance) true Inferred relationship Some
Ozanimod This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Sphingosine 1-phosphate receptor agonist true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Ozanimod hydrochloride This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. True Ozanimod Inferred relationship Some
Ozanimod (as ozanimod hydrochloride) 230 microgram oral capsule This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Ozanimod Inferred relationship Some 1
Product containing precisely ozanimod (as ozanimod hydrochloride) 460 microgram/1 each conventional release oral capsule (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Ozanimod Inferred relationship Some 1
Ozanimod-containing product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Ozanimod Inferred relationship Some 1
Product containing precisely ozanimod (as ozanimod hydrochloride) 920 microgram/1 each conventional release oral capsule (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Ozanimod Inferred relationship Some 1
Product containing ozanimod (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Ozanimod Inferred relationship Some 1
Ozanimod only product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Ozanimod Inferred relationship Some 1
Product containing only ozanimod (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Ozanimod Inferred relationship Some 1

This concept is not in any reference sets

Back to Start